Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
40 /100
MEDIUM RISK
Score updated Aug 28, 2026

MAIA — MAIA Biotechnology, Inc. Dilution Risk Tracker

Track MAIA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MAIA — Get alerts when the score changes →

As of August 28, 2026, MAIA Biotechnology, Inc. (MAIA) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. MAIA Biotechnology, Inc. has a market capitalization of $84.51M, 60.83M shares outstanding, 32 institutional holders tracked. Stored dilution-related fields include 452.7K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.33 approaching $1 threshold
🔔 Track MAIA — Get forecast alerts →

Market Data

Market Cap$84.51M
Shares Outstanding60.83M
Float51.46M
CashN/A
DebtN/A
Short InterestN/A

Institutional Holdings

32 institutional holders · 15.19M shares
#1 Solas Capital Management, LLC 4.30M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.15M shares
#3 Alyeska Investment Group, L.P. 2.50M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.06M
Days to Cover6.8
% of Float6.0%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2021-12-31
Form 4 INSIDER TRANSACTION 2026-08-24
Form 4 INSIDER TRANSACTION 2026-08-20
Full SEC filing analysis available with free account

Recent News

No recent news

Factual MAIA Dilution Snapshot

MAIA Biotechnology, Inc. (MAIA) has a DilutionScore of 40/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track MAIA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MAIA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MAIA
MAIA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.